Pharmacyclics Competitors and Similar CompaniesClear all
Pharmacyclics's competitors and similar companies include Ablynx and Virometix.
 Pharmacyclics Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. |  Ablynx Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. |  Virometix Virometix is a biotechnology company that develops vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases. | |
Founding Date | Founding Date 1991 | Founding Date 2001 | Founding Date 2009 |
Type | Type Subsidiary | Type Subsidiary | Type Private |
Tags | |||
Locations | Locations Sunnyvale, US HQ | Locations Gent, BE HQ | Locations Schlieren, CH HQ |
Employees | Employees 6551% decrease | Employees 1252% decrease | Employees 18 |
Financial | |||
Revenue (est.) | Revenue (est.) $729.7m (FY, 2014) | Revenue (est.) €85.2m (FY, 2016) | Revenue (est.) N/A |
Net income | Net income $86.1m (FY, 2014) | Net income (€1.1m) (FY, 2016) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 498.8m | Total funding raised $ 18.5m |
For sources of this data, please see the company profile
View Company Profiles
Ablynx
HQ
Gent, BE
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.
View companyVirometix
HQ
Schlieren, CH
Employees
18
Virometix is a biotechnology company that develops vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases.
View company